Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Atea Pharmaceuticals, Inc.
IPO Date: October 30, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $305.52M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.42 | 2.69%
Avg Daily Range (30 D): $0.05 | 1.52%
Avg Daily Range (90 D): $0.07 | 2.29%
Institutional Daily Volume
Avg Daily Volume: .71M
Avg Daily Volume (30 D): .35M
Avg Daily Volume (90 D): .35M
Trade Size
Avg Trade Size (Sh.): 118
Avg Trade Size (Sh.) (30 D): 96
Avg Trade Size (Sh.) (90 D): 112
Institutional Trades
Total Inst.Trades: 740
Avg Inst. Trade: $1.97M
Avg Inst. Trade (30 D): $.94M
Avg Inst. Trade (90 D): $.83M
Avg Inst. Trade Volume: .12M
Avg Inst. Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $2.58M
Avg Closing Trade (30 D): $.56M
Avg Closing Trade (90 D): $.56M
Avg Closing Volume: 182.87K
   
News
Jun 24, 2025 @ 11:00 AM
Atea Pharmaceuticals Announces Continued Advanceme...
Source: N/A
Apr 23, 2025 @ 11:00 AM
Atea Pharmaceuticals to Present New Data Showcasin...
Source: N/A
Apr 9, 2025 @ 11:00 AM
Atea Pharmaceuticals Announces Dosing of First Pat...
Source: N/A
Mar 26, 2025 @ 5:58 PM
Atea Pharmaceuticals Highlights Actions Underway t...
Source: N/A
Mar 21, 2025 @ 9:54 PM
Atea Pharmaceuticals Issues Statement Regarding Di...
Source: N/A
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $-1.65 $-.4 $-.4
Diluted EPS $-1.65 $-.4 $-.4
Revenue $ M $ M $ M
Gross Profit $ $ $
Net Income / Loss $ -139.49M $ -34.27M $ -33.54M
Operating Income / Loss $ -162.19M $ -39.04M $ -39.03M
Cost of Revenue $ $ $
Net Cash Flow $ -41.52M $ 54.7M $ -33.77M
PE Ratio    
Splits
Feb 14, 2018:   1:11